Get the Stockscreener App
38.96
0.57%
0.22
After Hours:
38.96
Atricure Inc Stock (ATRC) Latest News
AtriCure, Inc. to Host Earnings Call - ACCESS Newswire
26,035 Shares in AtriCure, Inc. (NASDAQ:ATRC) Acquired by AlphaCentric Advisors LLC - MarketBeat
HighMark Wealth Management LLC Has $2.56 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 20.4% - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Q4 2024 Earnings Call Transcript - MSN
Stifel Nicolaus Raises AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat
AtriCure (NASDAQ:ATRC) Price Target Raised to $45.00 at Oppenheimer - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Down 5.8%Here's What Happened - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) Stock - MarketBeat
AtriCure (NASDAQ:ATRC) Announces Earnings Results - MarketBeat
AtriCure (ATRC) Expected to Announce Earnings on Thursday - MarketBeat
AtriCure's (ATRC) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
AtriCure targets $517M-$527M revenue in 2025 with new product launches and international growth - MSN
Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS - MSN
(ATRC) Technical Pivots with Risk Controls - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at JPMorgan Chase & Co. - MarketBeat
Atricure Files For Mixed Shelf; Size Not DisclosedSEC Filing -February 14, 2025 at 03:53 pm EST - Marketscreener.com
AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know - MSN
AtriCure Inc. (ATRC) reports earnings - Quartz
AtriCure, Inc. SEC 10-K Report - TradingView
WCM Investment Management LLC Sells 23,785 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Silver Oak Securities Incorporated Invests $220,000 in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Earnings call transcript: AtriCure Q4 2024 revenue rises, stock dips By Investing.com - Investing.com Australia
AtriCure’s Earnings Call Highlights Strong Growth and Positive Outlook - TipRanks
AtriCure (NASDAQ:ATRC) Earns Market Outperform Rating from JMP Securities - MarketBeat
AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates - MSN
Earnings call transcript: AtriCure Q4 2024 revenue rises, stock dips - MSN
AtriCure price target raised to $57 from $53 at BTIG - TipRanks
Is AnaptysBio (ANAB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
AtriCure price target raised to $48 from $36 at Stifel - TipRanks
IAC, AtriCure, and Astera Labs: Top Stock Picks for Growth in 2025 - PUNE.NEWS
AtriCure price target raised to $66 from $61 at Canaccord - TipRanks
AtriCure price target raised to $50 from $40 at Piper Sandler - TipRanks
Oppenheimer Adjusts AtriCure Price Target to $45 From $36, Maintains Outperform Rating - Marketscreener.com
AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AtriCure, Inc. Reports Strong 2024 Financial Growth - TipRanks
4.97%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):